Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q41663662)
Watch
English
Anthracyclines-paclitaxel combinations in the treatment of breast cancer.
scientific article published on October 1997
In more languages
default for all languages
No label defined
No description defined
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9402164
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9402164%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 November 2019
review article
1 reference
stated in
Europe PubMed Central
title
Anthracyclines-paclitaxel combinations in the treatment of breast cancer
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9402164
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9402164%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 November 2019
author
Pierfranco Conte
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9402164
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9402164%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 November 2019
Alessandra Gennari
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9402164
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9402164%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 November 2019
author name string
P F Conte
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9402164
retrieved
6 October 2017
A Gennari
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9402164
retrieved
6 October 2017
publication date
1 October 1997
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9402164
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9402164%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 November 2019
published in
Annals of Oncology
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9402164
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9402164%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 November 2019
volume
8
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9402164
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9402164%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 November 2019
issue
10
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9402164
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9402164%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 November 2019
page(s)
939-943
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9402164
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9402164%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 November 2019
cites work
Chemotherapy and survival in advanced breast cancer: the inclusion of doxorubicin in Cooper type regimens
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1008208002779
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1008208002779
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Adjuvant cyclophosphamide, methotrexate, and fluorouracil versus fluorouracil, epirubicin, and cyclophosphamide chemotherapy in premenopausal women with axillary node-positive operable breast cancer: results of a randomized trial. The International
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1008208002779
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Adjuvant treatment of node-positive breast cancer with cyclophosphamide, doxorubicin, fluorouracil, and vincristine versus cyclophosphamide, methotrexate, and fluorouracil: final report after a 16-year median follow-up duration.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1008208002779
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Postsurgical adjuvant chemotherapy of stage II breast carcinoma with or without crossover to a non-cross-resistant regimen: a Cancer and Leukemia Group B study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1008208002779
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Paclitaxel as second and subsequent therapy for metastatic breast cancer: activity independent of prior anthracycline response
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1008208002779
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Multicenter, randomized comparative study of two doses of paclitaxel in patients with metastatic breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1008208002779
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase I/II study of 72-hour infusional paclitaxel and doxorubicin with granulocyte colony-stimulating factor in patients with metastatic breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1008208002779
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Sequence-dependent alteration of doxorubicin pharmacokinetics by paclitaxel in a phase I study of paclitaxel and doxorubicin in patients with metastatic breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1008208002779
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Taxol in combination with doxorubicin or etoposide. Possible antagonism in vitro
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1008208002779
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Schedule-dependent interaction between paclitaxel and doxorubicin in human cancer cell lines in vitro
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1008208002779
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Characteristics of the combination paclitaxel plus doxorubicin in breast cancer cell lines analyzed with the ATP-cell viability assay
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1008208002779
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Nonlinear pharmacokinetics and metabolism of paclitaxel and its pharmacokinetic/pharmacodynamic relationships in humans
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1008208002779
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cytotoxic studies of paclitaxel (Taxol) in human tumour cell lines
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1008208002779
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pharmacokinetics of taxol and doxorubicin administered alone and in combination by continuous 72-hour infusion
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1008208002779
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Theoretical and practical aspects of paclitaxel scheduling
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1008208002779
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Paclitaxel administered by 1-hour infusion. Preliminary results of a phase I/II trial comparing two schedules.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1008208002779
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Paclitaxel by 3-hour infusion in combination with bolus doxorubicin in women with untreated metastatic breast cancer: high antitumor efficacy and cardiac effects in a dose-finding and sequence-finding study.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1008208002779
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Combined doxorubicin and paclitaxel in advanced breast cancer: Effective and cardiotoxic
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1008208002779
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Risk factors for doxorubicin-induced congestive heart failure
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1008208002779
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pharmacokinetics and metabolism of epidoxorubicin and doxorubicin in humans
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1008208002779
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Drugs ten years later: epirubicin.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1008208002779
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Secondary alcohol metabolites mediate iron delocalization in cytosolic fractions of myocardial biopsies exposed to anticancer anthracyclines. Novel linkage between anthracycline metabolism and iron-induced cardiotoxicity
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1008208002779
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of adjuvant chemotherapy with or without anthracyclines on the activity and efficacy of first-line cyclophosphamide, epidoxorubicin, and fluorouracil in patients with metastatic breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1008208002779
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Conventional versus high-dose epidoxorubicin as single agent in advanced breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1008208002779
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Dose-response relationship of epirubicin-based first-line chemotherapy for advanced breast cancer: a prospective randomized trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1008208002779
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Dose-response relationship of epirubicin in the treatment of postmenopausal patients with metastatic breast cancer: a randomized study of epirubicin at four different dose levels performed by the Danish Breast Cancer Cooperative Group.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1008208002779
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Characterisation of complete responders to combination chemotherapy for advanced breast cancer: a retrospective EORTC Breast Group study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1008208002779
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Should we dream the impossible dream? The meaning of long-term survival in metastatic breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1008208002779
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1023/A:1008208002779
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9402164
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9402164%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 November 2019
PubMed publication ID
9402164
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9402164
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9402164%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 November 2019
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit